Aleor Dermaceuticals receives EIR from US FDA for Karakhadi formulation facility
Aleor Dermaceuticals Ltd. (Aleor), a 60:40 joint venture between Alembic Pharmaceuticals Ltd. (Alembic) and Orbicular Pharmaceutical Technologies Pvt. Ltd. (Orbicular), has received... Read More
Alembic Pharma acquires US-based drug developer Orbit Labs
Alembic Pharma today announced that it has completed the acquisition of US-based generic drug developer Orbit Laboratories LLC, along with its real... Read More
Alembic Pharma gets USFDA observations for Panelav plant
Drug firm Alembic Pharmaceuticals today said it has received four observations from the US health regulator after the inspection of Panelav facility.... Read More